Trial Profile
Open-label Prospective Randomized Study to Determine the Efficacy and Safety of Two Dosing Regimens of ACTHar in the Treatment of Proliferative Lupus Nephritis.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary) ; Mycophenolate mofetil
- Indications Lupus nephritis
- Focus Therapeutic Use
- 29 Aug 2014 New trial record